Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Net Cash Flow (2023 - 2026)

Grail's (GRAL) quarterly Net Cash Flow came in at -$127.3 million in Q2 2026, down 1830.05% on a YoY basis from $7.4 million in Q2 2025, and up 29.44% quarter-over-quarter from -$180.4 million in Q1 2026.

Analysis

Grail (GRAL) Net Cash Flow (2023 - 2026) Analysis & Trends

Grail (GRAL) has reported Net Cash Flow for 4 consecutive years, with -$127.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Cash Flow fell 1830.05% year-over-year to -$127.3 million; the trailing twelve-month figure through Jun 2026 stood at -$181.5 million (up 78.19% YoY), and the FY2025 full-year result was $39.3 million, down 66.19% from the prior year.
  • Net Cash Flow grew to -$127.3 million in Q2 2026 per GRAL's latest filing, from -$180.4 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $759.1 million in Q2 2024 and bottomed at -$639.6 million in Q4 2024.
  • Historically, Net Cash Flow has averaged -$23.8 million across 4 years, with a median of -$63.6 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Net Cash Flow soared 119.2% in 2025, then plunged 1830.05% in 2026.
  • Over 4 years, Net Cash Flow stood at -$46.8 million in 2023, then sank by 1266.45% to -$639.6 million in 2024, then jumped by 119.2% to $122.8 million in 2025, then slumped by 203.64% to -$127.3 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$127.3 million, -$180.4 million, and $122.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 3.57 Mn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 234.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -840.60 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 66.71 Mn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 78.50 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -130.62 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 42.79 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 11.18 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 92.31 Mn
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn -127.31 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -127.31 Mn
Mar 31, 2026 -180.43 Mn
Dec 31, 2025 122.83 Mn
Sep 30, 2025 3.43 Mn
Jun 30, 2025 -6.60 Mn
Mar 31, 2025 -80.40 Mn
Dec 31, 2024 -639.60 Mn
Sep 30, 2024 -105.55 Mn
Jun 30, 2024 759.12 Mn
Mar 31, 2024 102.17 Mn
Dec 31, 2023 -46.81 Mn
Oct 1, 2023 -86.58 Mn